News
![Reshma Ramlal for UKNow.jpg](/sites/default/files/article/images/Reshma%20Ramlal%20for%20UKNow.jpg)
LEXINGTON, Ky. (July 24, 2020) — Dr. Reshma Ramlal of the University of Kentucky Markey Cancer Center was recently named the 2020 Lexington Woman of the Year by the Leukemia & Lymphoma Society.
LEXINGTON, Ky. (July 22, 2020) — Early this spring, University of Kentucky virologist Rebecca Dutch answered some of our initial questions about COVID-19 and SARS-CoV-2, the virus that causes the disease. We asked her to take another look at the coronavirus pandemic.
LEXINGTON, Ky. (July 21, 2020) — A $3.2 million grant will support University of Kentucky College of Medicine research that could pave the way for a treatment for traumatic brain injury (TBI).
![she.jpg](/sites/default/files/article/images/she.jpg)
LEXINGTON, Ky. (July 14, 2020) — A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase (SMS) to facilitate colorectal cancer growth.
SMS is an enzyme that produces spermine from spermidine, which has been shown to be important for cell growth. However, excessive accumulation of spermidine can have harmful effects on cell viability. How cancer cells maintain a relatively high level of spermidine but below the toxic threshold to facilitate tumor growth is not well understood.
![Emilia-Galperin.jpeg](/sites/default/files/article/images/Emilia-Galperin.jpeg)
![190321ERINABNER13 copy_0.jpeg](/sites/default/files/article/images/190321ERINABNER13%20copy_0.jpeg)
![moore 1.jpg](/sites/default/files/article/images/moore%201.jpg)
![Artemis Annua_0.jpeg](/sites/default/files/article/images/Artemis%20Annua_0.jpeg)
![bircwh-conference.png](/sites/default/files/article/images/bircwh-conference.png)
The Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Program in the University of Kentucky College of Medicine is accepting applications to fill one position. Applications are due July 17, 2020.
![Screen Shot 2020-06-19 at 8.28.56 AM.png](/sites/default/files/article/images/Screen%20Shot%202020-06-19%20at%208.28.56%20AM.png)
LEXINGTON, Ky. (June 18, 2020) — Alpacas Big Boy, Blue Eyes and Emperor may hold the key to combating COVID-19. Their antibodies could offer a defense against SARS-CoV-2, the virus that causes the disease.
University of Kentucky College of Medicine researchers are using the special antibodies made by alpacas, called nanobodies, to help understand the novel coronavirus and potentially develop a treatment that could protect people from being infected.
![1132358570.jpg](/sites/default/files/article/images/1132358570.jpg)
LEXINGTON, Ky. (June 12, 2020) — In the wake of the COVID-19 pandemic, University of Kentucky experts quickly mobilized and pivoted their research to unite in the fight against the novel coronavirus.
UK researchers across many disciplines are addressing COVID-19’s medical challenges and beyond — including developing new personal protective equipment (PPE) materials, designing testing and diagnostic equipment, and examining the wider societal, economic and legal implications of the pandemic.
![Avinash Bhakta low res_0.jpg](/sites/default/files/article/images/Avinash%20Bhakta%20low%20res_0.jpg)
LEXINGTON, Ky. (June 8, 2020) – A study led by University of Kentucky Markey Cancer Center researchers showed that patients who already used opioids, sedatives or antidepressants prior to colorectal surgery experience significantly more complications post-surgery.
![placeholder-news_2.png](/sites/default/files/article/images/placeholder-news_2.png)
The NIH Center of Biomedical Research Excellence (COBRE) on Obesity and Cardiovascular Diseases, in collaboration with the Center for Clinical and Translational Sciences (CCTS) announce the availability of limited funds to support pilot projects focused on research examining obesity-associated diseases. Emphasis for support will be placed on pilot projects that examine the relationship between obesity and cardiovascular diseases, type 2 diabetes, COVID-19, cancer, or neurodegenerative diseases. These pilot grants are intended to assist investigators new to this area o
![org-fair-2019.jpg](/sites/default/files/article/images/org-fair-2019.jpg)
When Blake Herald began his journey at the University of Kentucky College of Medicine, he sensed there was something missing, something that would ensure a more inclusive environment for him and his fellow medical students. A collaboration with his peers and University leadership led to a solution.
![Gentry3.jpg](/sites/default/files/article/images/Gentry3.jpg)
LEXINGTON, Ky. (May 22, 2020) — University of Kentucky College of Medicine scientist Matthew Gentry is one of 20 recipients of a prestigious R35 grant from the National Institute of Neurological Disorders (NINDS) for his research on energy metabolism in the brain.
![GoldsteinLarryB20191029SLA.jpeg](/sites/default/files/article/images/GoldsteinLarryB20191029SLA.jpeg)
LEXINGTON, Ky. (May 26, 2020) — The COVID-19 pandemic, with reported cases in more than 200 countries, is a worldwide crisis challenging all aspects of health care systems around the globe. Managing the pandemic has required some drastic changes and allocation of resources. This is affecting the delivery of care for health conditions that can be unrelated to COVID-19. Experts in various fields across health care are working to adjust to the changes to ensure they provide the best care during this time while also protecting themselves and their colleagues.
![neuroscience team.png](/sites/default/files/article/images/neuroscience%20team.png)
Mere days after the COVID-19 pandemic forced limitations on research in laboratories, a team of neuroscience-related researchers from the UK College of Medicine figured out a way to keep the important discussions going, virtually.
The team’s solution: developing an online seminar series discussing a wide variety of topics in neuroscience, which is one of the six research priority areas in the UK Vice President for Research’s Research Priorities Initiative.
![190408Lofwall6395.jpeg](/sites/default/files/article/images/190408Lofwall6395.jpeg)
Since the $87 million HEALing Communities Study was announced just over a year ago, the University of Kentucky and its community and state partners have been working diligently to lay the groundwork to get the project up and running.